Skip to main content
. 2020 Apr 11;5(2):71–76. doi: 10.1016/j.ncrna.2020.03.001

Table 1.

Clinic characteristics of the study participants.

Characteristic Total n = 120 T2D n = 60 Without T2D n = 60 P
Age (years) 49.9 ± 6.3 50.2 ± 6.1 49.6 ± 6.5 0.630a
Years of diagnosis 2.8 ± 1.7
Gender, n (%)
 Male 38 (31.7) 19 (31.7) 19 (31.7) 1.0b
 Female 82 (68.3) 41 (68.3) 41 (68.3)
BMI (kg/m2) 28.9 ± 5.4 30.2 ± 5.4 27.7 ± 5.1 0.012a
WC (cm) 93 ± 12.5 96.8 ± 13.7 89.3 ± 10.0 <0.001a
 < 88, n (%) 60 (50) 23 (38.3) 37 (61.7) 0.011b
 ≥ 88, n (%) 60 (50) 37 (61.7) 23 (38.3)
Systolic BP (mmHg) 113 ± 14 113 ± 16 113 ± 13 0.975a
Diastolic BP (mmHg) 78 ± 11 80 ± 12 76 ± 10 0.067a
 BP < 135 or 85, n (%) 92 (76.7) 40 (66.7) 52 (86.7) 0.010b
 BP ≥ 135 or 85, n (%) 28 (23.3) 20 (33.3) 8 (13.3)
Glucose (mg/dL) 94.5 (87–120) 120 (102–158) 87.5 (83–92) <0.001c
 < 100, n (%) 73 (60.8) 13 (21.7) 60 (100) <0.001b
 ≥ 100, n (%) 47 (78.2) 47 (78.3) 0
Triglycerides (mg/dL) 168 (125.5–229) 188 (140–257) 142 (101–196.5) <0.001c
 < 150, n (%) 52 (43.3) 18 (30) 34 (56.7) 0.003
 ≥ 150, n (%) 68 (56.7) 42 (70) 26 (43.3)
HDL-c (mg/dL) 45.5 (39–55) 41 (35.5–49) 50.5 (41.5–57) <0.001c
 ≥ 40 M or 50 F, n (%) 62 (51.7) 22 (36.7) 40 (66.7) 0.001
 < 40 M or 50 F, n (%) 58 (48.3) 38 (63.3) 20 (33.3)
LDL-c (mg/dL) 140 ± 36 140 ± 34 142 ± 38 0.731a
Cholesterol (mg/dL) 201 ± 45 200 ± 41 202 ± 48 0.873a
Metabolic syndrome, n (%) 41 (34.2) 35 (58.3) 6 (10) <0.001b
HbA1c (%) 5.6 (4.9–7.2)

The data are shown as means ± standard deviation, medians and percentiles (p25th - p75th) or as indicated.

T2D, Type-2 diabetes; BMI, Body mass index; WC, Waist circumference; BP, Blood pressures; HDL-c, High-density lipoprotein cholesterol; LDL-c, Low-density lipoprotein cholesterol; HbA1c, Glycosylated hemoglobin.

a

t-test.

b

Chi-square test.

c

Mann-Whitney test.